Share this article
Share this article
NEW YORK, May 11, 2021 /PRNewswire/ Nanowear www.nanowearinc.com, the leading nanotechnology and A.I.-based remote diagnostic company, today announced a commercial distribution partnership with a world leading aesthetic and reconstructive surgical device-manufacturer, to enhance and optimize post-surgical recovery for both patients and surgeons. With over 18 million annual procedures in the U.S. alone, we re proud to deploy our remote diagnostics platform to patients recovering from aesthetic and reconstructive surgery while providing digital signatures to the surgical teams who care for these patients, said Venk Varadan, co-founder & CEO of Nanowear.
Gender-neutral and size-adjustable, Nanowear s SimpleSENSE platform effectively replaces the digital stethoscope, multi-channel electrocardiograph (ECG) monitor, capnogram respiration machine, and blood pressure cuff by providing a diagnostic quality monitoring system that remotely